TY - JOUR
T1 - Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
AU - Local Burden of Disease Anaemia Collaborators
AU - Kinyoki, Damaris
AU - Osgood-Zimmerman, Aaron E.
AU - Bhattacharjee, Natalia V.
AU - Schaeffer, Lauren E.
AU - Lazzar-Atwood, Alice
AU - Lu, Dan
AU - Ewald, Samuel B.
AU - Donkers, Katie M.
AU - Letourneau, Ian D.
AU - Collison, Michael
AU - Schipp, Megan F.
AU - Abajobir, Amanuel
AU - Abbasi, Sima
AU - Abbasi, Nooshin
AU - Abbasifard, Mitra
AU - Abbasi-Kangevari, Mohsen
AU - Abbastabar, Hedayat
AU - Abd-Allah, Foad
AU - Abdelalim, Ahmed
AU - Abd-Elsalam, Sherief M.
AU - Abdoli, Amir
AU - Abdollahpour, Ibrahim
AU - Abedi, Aidin
AU - Abolhassani, Hassan
AU - Abraham, Biju
AU - Abreu, Lucas Guimarães
AU - Abrigo, Michael R.M.
AU - Abualhasan, Ahmed
AU - Abu-Gharbieh, Eman
AU - Abushouk, Abdelrahman I.
AU - Accrombessi, Manfred Mario Kokou
AU - Adabi, Maryam
AU - Adebayo, Oladimeji M.
AU - Adegbosin, Adeyinka Emmanuel
AU - Adekanmbi, Victor
AU - Adetokunboh, Olatunji O.
AU - Adeyinka, Daniel Adedayo
AU - Adham, Davoud
AU - Advani, Shailesh M.
AU - Agasthi, Pradyumna
AU - Aghaali, Mohammad
AU - Ahmad, Sohail
AU - Ahmad, Tauseef
AU - Ahmadi, Keivan
AU - Ahmadi, Sepideh
AU - Ahmed, Muktar Beshir
AU - Aichour, Miloud Taki Eddine
AU - Aji, Budi
AU - Akinyemi, Oluwaseun Oladapo
AU - Aklilu, Addis
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/10
Y1 - 2021/10
N2 - Anemia is a globally widespread condition in women and is associated with reduced economic productivity and increased mortality worldwide. Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels. Additionally, we provide subnational disparity analyses to provide a comprehensive overview of anemia prevalence inequalities within these countries and predict progress toward the World Health Organization’s Global Nutrition Target (WHO GNT) to reduce anemia by half by 2030. Our results demonstrate widespread moderate improvements in overall anemia prevalence but identify only three LMICs with a high probability of achieving the WHO GNT by 2030 at a national scale, and no LMIC is expected to achieve the target in all their subnational administrative units. Our maps show where large within-country disparities occur, as well as areas likely to fall short of the WHO GNT, offering precision public health tools so that adequate resource allocation and subsequent interventions can be targeted to the most vulnerable populations.
AB - Anemia is a globally widespread condition in women and is associated with reduced economic productivity and increased mortality worldwide. Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels. Additionally, we provide subnational disparity analyses to provide a comprehensive overview of anemia prevalence inequalities within these countries and predict progress toward the World Health Organization’s Global Nutrition Target (WHO GNT) to reduce anemia by half by 2030. Our results demonstrate widespread moderate improvements in overall anemia prevalence but identify only three LMICs with a high probability of achieving the WHO GNT by 2030 at a national scale, and no LMIC is expected to achieve the target in all their subnational administrative units. Our maps show where large within-country disparities occur, as well as areas likely to fall short of the WHO GNT, offering precision public health tools so that adequate resource allocation and subsequent interventions can be targeted to the most vulnerable populations.
UR - http://www.scopus.com/inward/record.url?scp=85117122610&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117122610&partnerID=8YFLogxK
U2 - 10.1038/s41591-021-01498-0
DO - 10.1038/s41591-021-01498-0
M3 - Article
C2 - 34642490
AN - SCOPUS:85117122610
SN - 1078-8956
VL - 27
SP - 1761
EP - 1782
JO - Nature Medicine
JF - Nature Medicine
IS - 10
ER -